HK1084023A1 - Glycosaminoglycans for treating emotional dysfunctions - Google Patents

Glycosaminoglycans for treating emotional dysfunctions

Info

Publication number
HK1084023A1
HK1084023A1 HK06104250A HK06104250A HK1084023A1 HK 1084023 A1 HK1084023 A1 HK 1084023A1 HK 06104250 A HK06104250 A HK 06104250A HK 06104250 A HK06104250 A HK 06104250A HK 1084023 A1 HK1084023 A1 HK 1084023A1
Authority
HK
Hong Kong
Prior art keywords
glycosaminoglycans
emotional dysfunctions
treating emotional
dysfunctions
anxiety
Prior art date
Application number
HK06104250A
Other languages
English (en)
Inventor
Cornelli Umberto
De Ambrosi Luigi
Lorens Stanley
Fareed Jawed
Lee John
Hanin Israel
Mervis Ronald
Original Assignee
Cornelli Umberto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornelli Umberto filed Critical Cornelli Umberto
Publication of HK1084023A1 publication Critical patent/HK1084023A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK06104250A 2003-05-21 2006-04-07 Glycosaminoglycans for treating emotional dysfunctions HK1084023A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001023A ITMI20031023A1 (it) 2003-05-21 2003-05-21 Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
PCT/EP2004/050860 WO2004103381A1 (en) 2003-05-21 2004-05-19 Glycosaminoglycans for treatment emotional dysfunctions

Publications (1)

Publication Number Publication Date
HK1084023A1 true HK1084023A1 (en) 2006-07-21

Family

ID=30131059

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06104250A HK1084023A1 (en) 2003-05-21 2006-04-07 Glycosaminoglycans for treating emotional dysfunctions

Country Status (21)

Country Link
US (1) US7812005B2 (zh)
EP (1) EP1631298B8 (zh)
JP (1) JP4757197B2 (zh)
KR (1) KR20060025142A (zh)
CN (1) CN100377717C (zh)
AT (1) ATE373480T1 (zh)
AU (1) AU2004241748B2 (zh)
CA (1) CA2526201A1 (zh)
DE (1) DE602004009068T2 (zh)
DK (1) DK1631298T3 (zh)
ES (1) ES2294507T3 (zh)
HK (1) HK1084023A1 (zh)
IL (1) IL171981A (zh)
IT (1) ITMI20031023A1 (zh)
NO (1) NO20056089L (zh)
NZ (1) NZ544238A (zh)
PL (1) PL1631298T3 (zh)
PT (1) PT1631298E (zh)
RU (1) RU2353371C2 (zh)
WO (1) WO2004103381A1 (zh)
ZA (1) ZA200510132B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
CN107760713B (zh) * 2016-08-23 2020-05-05 中国科学院上海药物研究所 一种非人哺乳动物神经精神疾病动物模型的建立方法及其用途
CN112438991B (zh) * 2019-08-29 2024-03-15 鲁南制药集团股份有限公司 肝素、或其衍生物、或其可药用盐的医药用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
IT1205042B (it) * 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FR2763848B1 (fr) * 1997-05-28 2000-01-28 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
FR2763849B1 (fr) * 1997-05-28 2000-09-15 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
JP4412756B2 (ja) * 1998-02-26 2010-02-10 生化学工業株式会社 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物
IT1312107B1 (it) * 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile

Also Published As

Publication number Publication date
AU2004241748B2 (en) 2010-05-13
PT1631298E (pt) 2007-12-31
US20060205690A1 (en) 2006-09-14
IL171981A (en) 2010-04-15
US7812005B2 (en) 2010-10-12
JP2006528670A (ja) 2006-12-21
EP1631298A1 (en) 2006-03-08
ITMI20031023A0 (it) 2003-05-21
IL171981A0 (en) 2006-04-10
ZA200510132B (en) 2006-08-30
NZ544238A (en) 2008-08-29
JP4757197B2 (ja) 2011-08-24
ATE373480T1 (de) 2007-10-15
AU2004241748A1 (en) 2004-12-02
RU2353371C2 (ru) 2009-04-27
DE602004009068T2 (de) 2008-06-19
RU2005138517A (ru) 2006-08-27
WO2004103381A1 (en) 2004-12-02
CA2526201A1 (en) 2004-12-02
DE602004009068D1 (de) 2007-10-31
PL1631298T3 (pl) 2008-04-30
DK1631298T3 (da) 2008-01-28
ITMI20031023A1 (it) 2004-11-22
ES2294507T3 (es) 2008-04-01
CN1791416A (zh) 2006-06-21
KR20060025142A (ko) 2006-03-20
NO20056089L (no) 2006-02-09
EP1631298B8 (en) 2008-12-24
CN100377717C (zh) 2008-04-02
EP1631298B1 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
MY141476A (en) 5ht2c receptor modulators
TW200519075A (en) Novel compounds
TW200635903A (en) Therapeutic agents
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
MXPA05010682A (es) Compuestos novedosos.
TW200510416A (en) P38 inhibitors and methods of use thereof
JO2686B1 (en) Vehicles
TW200612892A (en) Novel compounds
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
TW200504034A (en) Therapeutic agents
TW200633986A (en) Therapeutic agents
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MY147677A (en) Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
TW200505865A (en) Compounds useful for the treatment of diseases
BG108180A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
MXPA05013016A (es) Gaboxadol para el tratamiento de la depresion y otros trastornos afectivos.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120519